Cannara Biotech (LOVFF), a vertically integrated premium cannabis producer with two mega facilities in Québec totaling over 1,650,000 sq. ft, has announced an upcoming investor webcast scheduled for June 25, 2025, at 2:00 PM ET. During the presentation, CFO Nicholas Sosiak will discuss key aspects of Cannara's business operations, followed by an interactive Q&A session with investors. The webcast will be accessible through a pre-registration link, and an archived version will be available on the company's investor relations website.
Cannara Biotech (LOVFF), produttore premium di cannabis integrato verticalmente con due mega strutture in Québec che coprono oltre 1.650.000 piedi quadrati, ha annunciato un webcast per investitori previsto per il 25 giugno 2025 alle 14:00 ET. Durante la presentazione, il CFO Nicholas Sosiak illustrerà gli aspetti chiave delle operazioni aziendali di Cannara, seguito da una sessione interattiva di domande e risposte con gli investitori. Il webcast sarà accessibile tramite un link di preregistrazione, e una versione registrata sarà disponibile sul sito web delle relazioni con gli investitori della società.
Cannara Biotech (LOVFF), un productor premium de cannabis integrado verticalmente con dos mega instalaciones en Québec que suman más de 1,650,000 pies cuadrados, ha anunciado una próxima transmisión web para inversores programada para el 25 de junio de 2025 a las 2:00 PM ET. Durante la presentación, el CFO Nicholas Sosiak hablará sobre aspectos clave de las operaciones comerciales de Cannara, seguido de una sesión interactiva de preguntas y respuestas con los inversores. La transmisión será accesible mediante un enlace de preregistro, y una versión archivada estará disponible en el sitio web de relaciones con inversores de la compañía.
Cannara Biotech(LOVFF)� 퀘벡� 165� 평방피트 이상� � 개의 대규모 시설� 보유� 수직 통합 프리미엄 대마초 생산업체�, 2025� 6� 25� 오후 2�(동부시간)� 예정� 투자� 웹캐스트� 발표했습니다. 발표 � CFO� Nicholas Sosiak가 Cannara� 주요 사업 운영 사항� 설명하고, 이후 투자자들과의 실시� 질의응답 세션� 진행됩니�. 웹캐스트� 사전 등록 링크� 통해 접속� � 있으�, 녹화본은 회사 투자� 관� 웹사이트에서 제공� 예정입니�.
Cannara Biotech (LOVFF), producteur premium de cannabis intégré verticalement avec deux méga installations au Québec totalisant plus de 1 650 000 pieds carrés, a annoncé un webinaire pour investisseurs prévu le 25 juin 2025 à 14h00 ET. Lors de cette présentation, le CFO Nicholas Sosiak abordera les aspects clés des opérations commerciales de Cannara, suivi d'une session interactive de questions-réponses avec les investisseurs. Le webinaire sera accessible via un lien de préinscription, et une version enregistrée sera disponible sur le site web des relations investisseurs de la société.
Cannara Biotech (LOVFF), ein vertikal integrierter Premium-Cannabisproduzent mit zwei Mega-Anlagen in Québec mit einer Gesamtfläche von über 1.650.000 Quadratfuß, hat eine bevorstehende Investoren-Webcast für den 25. Juni 2025 um 14:00 Uhr ET angekündigt. Während der Präsentation wird CFO Nicholas Sosiak wichtige Aspekte der Geschäftstätigkeit von Cannara erläutern, gefolgt von einer interaktiven Fragerunde mit den Investoren. Der Webcast ist über einen Vorregistrierungslink zugänglich, und eine archivierte Version wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
Positive
None.
Negative
None.
MONTREAL, June 19, 2025 (GLOBE NEWSWIRE) -- (�Cannara�, “the Company�, �us� or �we�) () () (), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000sq. ft, today announced that it will host a webcast investor presentation onWednesday, June 25, 2025, at2:00 PM ET. During the webcast,Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A session. To listen to the webcast or to ask questions during the live event, please pre-register at the following link:
Webcast Link:
An archived version of the webcast and presentation will be available on the Company's website,
CONTACT
Nicholas Sosiak, CPA, CA Chief Financial Officer Ծ찪ԲԲ.�
ܴdz Kǰdz� President & Chief Executive Officer� dzԲԲ.�
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ABOUT CANNARA
() () (), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000sq. ft., providing the Company with 100,000kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit�.
FAQ
When is Cannara Biotech (LOVFF) hosting its investor webcast in 2025?
Cannara Biotech is hosting its investor webcast on Wednesday, June 25, 2025, at 2:00 PM ET.
Who will be presenting at the Cannara Biotech (LOVFF) investor webcast?
Nicholas Sosiak, Chief Financial Officer of Cannara Biotech, will be conducting the presentation.
How large are Cannara Biotech's (LOVFF) facilities in Quebec?
Cannara Biotech operates two mega facilities in Quebec spanning over 1,650,000 square feet.
Where can investors access the archived version of Cannara Biotech's (LOVFF) webcast?
The archived version of the webcast and presentation will be available on the company's website at https://investors.cannara.ca/
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.